NBC News on MSN2d
Biden proposes weight loss drug coverage for people on Medicare and Medicaid
Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration ...
Biden wants Medicare, Medicaid to cover weight-loss drugs
The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...
Malaysia Sun2h
Obese citizens on weight-loss drugs could get Medicare, Medicaid
The Biden administration has proposed a new rule that would allow Medicare and Medicaid to cover popular weight-loss ...
Biden for Medicare, Medicaid payments for weight-loss drugs
The Biden administration has proposed a new rule that would allow Medicare and Medicaid to cover popular weight-loss medications like Wegovy and Zepbound ...
Healthcare Dive2d
Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...
Fierce Healthcare2d
Biden proposes Medicare, Medicaid cover anti-obesity drugs
The Centers for Medicare & Medicaid Services is attempting to cover anti-obesity medications under Medicare Part D and ...
Arkansas Times2d
Biden administration unveils plan to cover weight loss meds under Medicare, Medicaid
Medicare and Medicaid would cover Ozempic and other popular weight-loss drugs starting in 2026 under a proposed new federal ...
Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and ...